Human parainfluenza virus fusion complexglycoproteins imaged in action

人副流感病毒融合复合物糖蛋白的活动成像

• 批准号: 10352390
• 负责人: Tara Marcink
• 金额: $ 7.25万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-12-15 至 2023-12-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10352390
• 关键词: 3-Dimensional; Architecture; Binding Proteins; Biological; Bronchiolitis; Cell fusion; Cell membrane; Cells; Cellular Membrane; Cessation of life; Child; Chimeric Proteins; Complex; Croup; Cryo-electron tomography; Data; Data Collection; Development; Family; Future; Genome; Glean; Glycoproteins; Goals; Head; Health; Hemagglutinin; Human; Image; Infant; Infection; Knowledge; Laboratories; Lead; Location; Measles; Mediating; Membrane; Membrane Glycoproteins; Methods; Modeling; Molecular Conformation; Mumps; Nature; Neuraminidase; Para-Influenza Virus Type 3; Paramyxovirus; Pathogenesis; Pathogenicity; Peptides; Phase; Play; Pneumonia; Process; Proteins; Publications; RNA; Receptor Cell; Research; Research Training; Resolution; Respiratory Disease; Role; Scientist; Series; Site; Structure; Surface; Testing; Thermodynamics; Time; Training; Vaccine Design; Vaccines; Viral; Viral Fusion Proteins; Virion; Virus; Virus Receptors; cellular imaging; computerized data processing; effective therapy; experimental study; human pathogen; innovation; insight; member; parainfluenza virus; premature; prevent; receptor; receptor binding; serial imaging; small molecule; structural biology; tool; training project; vaccine development; virology

Project Summary Infection by human parainfluenza viruses (HPIVs) causes important lower respiratory diseases including croup, bronchiolitis and pneumonia, that lead to illness or death in millions of infants and young children worldwide. There are no vaccines or effective treatments. During viral entry, the first step of infection, the viral fusion complex – comprised of the surface glycoproteins HN (receptor-binding protein; hemagglutinin-neuraminidase) and F (fusion protein) – mediates fusion upon receptor binding. HN triggers F to undergo conformational rearrangements that promote viral entry, and these key steps are not understood. The overall goal of this proposal is to capture serial intermediate states of the HPIV3 HN-F fusion complex in native state during activation and examine the fusion mechanism using cryo-electron tomography (ET). Cryo-ET will provide direct structural evidence related to our proposed mechanisms of action of the glycoprotein complex during viral entry. Aim 1 will focus on HN’s protective role in preventing premature activation of F-mediated fusion, using cryo-ET to compare HN-F specific complexes (1.1) and small molecules that interact with HN and induce it to activate F (1.2). In aim 2, we will capture and visualize the structural rearrangements in the HN-F fusion complex during serial stages of the fusion process. Execution of these aims along with the training as outlined will prepare me to advance my field in a fashion that applies structural biology methods to important mechanistic questions in virology. I expect to characterize in unprecedented detail how HN triggers F-mediated fusion for HPIV3 and provide clear answers about the process of viral fusion that have been central and puzzling – while at the same time leading to development of cutting-edge methods in cryo-ET. Using this approach, it will be possible not only to test hypotheses that attempt to simplify the nature of the HN-F relationship, but to examine the fusion complex at specific intermediate points in time in native, authentic configurations as they exist on the virus. Our experiments will explain how the necessary intermediates form, and the mechanistic data gleaned from our results can then guide antiviral strategies, as this understanding is a prerequisite for developing ways to disable the fusion/entry phase of infection. The project is innovative in both technical and conceptual aspects and thus provides an ideal training vehicle for me to develop into a rigorous and creative independent scientist.

项目摘要 人副流感病毒（HPIV）感染引起重要的下呼吸道疾病，包括哮吼， 细支气管炎和肺炎，导致全世界数百万婴儿和幼儿患病或死亡。 没有疫苗或有效的治疗方法。在病毒进入，感染的第一步，病毒融合复合物 - 由表面糖蛋白HN（受体结合蛋白;血凝素-神经氨酸酶）和F （融合蛋白）-在受体结合时介导融合。HN触发F进行构象转变 重组促进病毒进入，这些关键步骤还不清楚。这个项目的总体目标是 一个建议是捕获HPIV 3 HN-F融合复合物在天然状态下的连续中间状态， 激活，并使用冷冻电子断层扫描（ET）检查融合机制。Cryo-ET将提供直接 与我们提出的糖蛋白复合物在病毒进入过程中的作用机制有关的结构证据。 目的1将集中在HN的保护作用，防止过早激活F-介导的融合，使用冷冻ET 比较HN-F特异性复合物（1.1）和与HN相互作用并诱导其激活F的小分子 （一、二）.在目标2中，我们将捕获并可视化HN-F融合复合物中的结构重排， 融合过程的一系列阶段。执行这些目标沿着培训概述将准备我 以一种将结构生物学方法应用于重要的机械问题的方式推进我的领域， 病毒学 我期望以前所未有的细节来表征HN如何触发HPIV 3的F介导的融合，并提供清晰的 关于病毒融合过程的答案一直是中心和令人困惑的-同时导致 发展尖端的冷冻ET方法使用这种方法，不仅可以测试 这些假说试图简化HN-F关系的性质，但要检查融合复合物， 特定的中间时间点，在本地，真实的配置，因为他们存在的病毒。我们的实验 我将解释必要的中间体是如何形成的，从我们的结果中收集的机械数据可以 指导抗病毒策略，因为这种理解是开发禁用融合/进入方法的先决条件 感染阶段。该项目在技术和概念方面都具有创新性，因此提供了一个理想的 这是我成长为一个严谨和有创造力的独立科学家的训练工具。